Search Results - "Seger, Nelly"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma by Zhang, Yifan, Chen, Yi, Yang, Chen, Seger, Nelly, Hesla, Asle C., Tsagkozis, Panagiotis, Larsson, Olle, Lin, Yingbo, Haglund, Felix

    Published in Modern pathology (01-11-2021)
    “…Chondrosarcomas are the second most common malignant bone tumor. Activating promoter mutations in telomerase reverse transcriptase (TERT) was recently…”
    Get full text
    Journal Article
  2. 2

    hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality by Lin, Yingbo, Seger, Nelly, Chen, Yi, Hesla, Asle C., Wejde, Johan, Ghaderi, Mehran, Tsagkozis, Panagiotis, Larsson, Olle, Haglund, Felix

    Published in Modern pathology (01-12-2018)
    “…Chondrosarcomas are malignant skeletal tumors with chondroid differentiation. Prognosis is largely dependent on histological grading, which suffer from…”
    Get full text
    Journal Article
  3. 3

    Telomerase promoter mutations and copy number alterations in solitary fibrous tumours by Lin, Yingbo, Seger, Nelly, Tsagkozis, Panagiotis, Hesla, Asle C, Ghaderi, Mehran, Chen, Yi, Ehnman, Monika, Warsito, Dudi, Wejde, Johan, Larsson, Olle, Haglund, Felix

    Published in Journal of clinical pathology (01-09-2018)
    “…Solitary fibrous tumour (SFT) is an infrequently metastasising mesenchymal tumour defined by the fusion gene. Activating mutations in the ( ) gene promoter has…”
    Get more information
    Journal Article